Skip to content
Navigate to homepage - Cerba Research

Pre-clinical Services

We offer a wide range of preclinical services to evaluate the safety, efficacy, PK, and toxicology of antivirals, drugs, antibodies, and vaccines

As a leading clinical trial diagnostic and operation services company, specialized in virology and immunology, Cerba Research provides a wide range of preclinical services to test the safety, effectiveness, PK, and (immune) toxicology of antivirals, drugs, antibodies, and vaccines that target infectious diseases.

We have extensive experience with multiple viral targets such as such as Influenza, RSV, hMPV, MERS Coronavirus, SARS-CoV, SARS-CoV-2, Varicella Zoster Virus, Measles Virus, Dengue Virus, Monkeypox Virus, Rabies Virus, Polio Virus and more.

Several animal models are available, including ferrets, mice, rabbits, guinea pigs, cotton rats, and others.

Assays for Preclinical Services

We also perform histopathology assays to evaluate the disease progression of viruses and provide diagnostic assays that have been validated to quantify cell-mediated and serological immune responses and assays to detect the presence of viruses and quantify virus load in various tissues. Assays can be tailor made to meet customer demand according to the 3 R’s.

At Cerba Research, we are committed to advancing the field of virology by developing innovative models that monitor therapeutic efficacy and the development of antiviral resistance. Our in-house team of experts is dedicated to developing models applicable to a wide range of viral, gene therapy (including AAV vectors), bacterial and oncological targets.

What We Can Offer in Preclinical Services

Our highly skilled professionals offer (Pre) Clinical Test Services for Vaccines, Anti Virals and Diagnostics Development.

In Vivo

  • Vaccine efficacy
  • Antiviral efficacy
  • Pharmacokinetics
  • Non-clinical efficacy (Animal Rule)
  • Model development
  • Customized models (Immune Suppression)
  • Board Certified Pathologist
  • Full Pathology (inc. Immunostains)

In vitro

  • Preclinical sample testing
  • In vitro / ex vivo models for early stage efficacy testing (3Rs)
  • Clinical sample testing (when polio is involved)

Our Pre-clinical Laboratories:

ML2 and ML3 laboratories

Basic cell culture, Virus culture (ML2 and ML3), Molecular virology, Serology and Histological pre-processing

Polio Virus laboratory:

Class II BSCs, 1 Triple Class II BSC, and Incubators Storage (-80, -20 and +4)

Quality Assurance and Regulatory Compliance

Delivering reliable and high-quality data is our utmost priority. Cerba Research Diagnostic Laboratory has adopted a high-quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, GLP, GCLP, GSLP, and expanded with elements of GCP, to comply with regulatory requirements and facilitate regulatory submissions. Our commitment to quality ensures that your research findings are robust, reliable, and ready for further development.

State-Of-The-Art Containment Facilities

Our BSL-2 and BSL-3 facilities allow for complicated experiments with extremely pathogenic viruses, promoting the development of research techniques to study highly prevalent diseases such as COVID-19.

5 scientists standing in a circle smiling and looking down at the camera. They have all put their hands together in a huddle

Experienced Staff

The combination of our highly advanced BSL2 and BSL3 animal facilities with our highly qualified scientists generates successful study outcomes for extremely effective preclinical services.

Streamlined Services

We promote simple micro-management methods and give a clear overview of results. By working with fewer vendors, services are easy to navigate and give you access to detailed evidence for your research.

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our experts and see how we can help advance your clinical trial

Contact Us